Chevron Left
Zurück zu Lymphoedema: Monitoring & Intervention After Breast Cancer

Bewertung und Feedback des Lernenden für Lymphoedema: Monitoring & Intervention After Breast Cancer von Macquarie University

4.9
Sterne
26 Bewertungen
9 Bewertungen

Über den Kurs

Lymphoedema following breast cancer treatment is a poorly understood and under-researched condition which can significantly impact physical and psychological function, reduce quality of life and result in substantial cost burdens to both patients and the healthcare system. In these interactive modules we will cover an introduction to lymphoedema, lymphatic physiology and anatomy, assessment and treatment, as well as utilise case studies to understand the prospective surveillance and early intervention model of care in breast cancer rehabilitation. This course is brought to you by the Australian Lymphoedema Education, Research and Treatment program (ALERT) at Macquarie University, Sydney, Australia....

Top-Bewertungen

Filtern nach:

1 - 9 von 9 Bewertungen für Lymphoedema: Monitoring & Intervention After Breast Cancer

von Aedrian A

25. Dez. 2020

This is an excellent comprehensive overview of breast cancer-associated lymphedema and its monitoring and management.

von Cynthia J S

14. Nov. 2020

love the approach and teaching

von Lisa R

3. Mai 2021

An engaging course. Easy to navigate and written for ease of comprehension. Up to date material reinforcing the positive outcomes for Breast Cancer related Lymphoedema if the Early intervention model of care is adopted.

von Robyn H

15. März 2021

really good

up to date

emphasises importance of treating subclinical lymphoedema

value of BIS

importance of early intervention and detection

emphasises my awareness lack of services available to deliver best practice

von Elisabete R

23. Feb. 2021

course of great quality, well-explained subject and easy understanding

von Chandrakant D M

12. Jan. 2021

nice course

von Anita K

11. Nov. 2020

Great

von Abhishek

28. Juni 2021

Good

von Sandra V

17. Nov. 2020

B